Skip Navigation

Emergency Response IRB

In early March 2020, at the beginning of the COVID-19 pandemic in the United States, the JHM Office of Human Subjects Research began to strategize ways to review COVID-19 related research in a timely and systematic manner. To support the effort, a group of experts drawn from the existing JHM IRB membership were formulated to review COVID-19 related research.

JHM IRB 3 along with experts drawn from the other JHM committees who serve as alternates for JHM IRB 3 members meet regularly as the Emergency Response IRB.

The members have expertise in a number of areas including infectious diseases, pharmacy and therapeutics, research ethics and general internal medicine. The Emergency Response IRB is dedicated to the review of COVID-19 related new protocol applications, and change in research applications for currently approved research adding some aspect of COVID-19 related research.

The members of the Emergency Response IRB are:

  • Richard Moore, MD
    Chairman
    Professor of Internal Medicine
     
  • Mary Catherine Beach, M.D.,M.P.H.
    Ethicist
    Professor, Division of General Internal Medicine
     
  • Roy Brower, M.D
    Professor, Pulmonary
     
  • Reverend Charles Goods
    Unaffiliated/Non-Scientific Member
     
  • Bhakti Hansoti, MBCHB, MPH, PHD
    Assistant Professor, Emergency Medicine
     
  • Craig Hendrix, M.D.
    P & T Committee
    Professor, Clinical Pharmacology
     
  • Joseph Carrese, M.D.
    Ethicist
    Professor, Medicine Division of General Internal Medicine
     
  • Reverend Calvin Keene
    Unaffiliated Member/Non-Scientific Member
     
  • Howard Lederman M.D., Ph.D.
    Professor, Pediatrics & Medicine
     
  • Verena Jorgensen, M.D.
    Pediatric Endocrinology
     
  • Jonathan Zenilman, M.D.
    Professor, Infectious Diseases

Last Updated 7/1/2021

back to top button